Results for tag: "Trichotillomania Drug"

Trichotillomania is a mental disorder characterized by the recurrent urge to pull out one's own hair. It is classified as an impulse control disorder and is included in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Treatment for trichotillomania typically involves a combination of psychotherapy, medications, and lifestyle changes. Central nervous system (CNS) drugs are commonly used to treat trichotillomania, as they can help reduce the urge to pull out one's hair. These drugs include selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and atypical antipsychotics. The trichotillomania drug market is composed of a variety of pharmaceutical companies that produce and market CNS drugs for the treatment of trichotillomania. Some of the major players in this market include Pfizer, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, and Novartis. Show Less Read more